Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Vericel Corp's peak revenue was $124.2M in 2021. The peak quarterly revenue was $179.3M in 2025(q2).
Vericel Corp's revenue increased from $4.4m in 2014 to $45.9M currently. That's a 936.15% change in annual revenue.
| Fiscal year / year | Vericel Corp revenue |
|---|---|
| 2014 | $4.4M |
| 2015 | $28.8M |
| 2016 | $51.2M |
| 2017 | $54.4M |
| 2018 | $63.9M |
| 2019 | $90.9M |
| 2020 | $117.9M |
| 2021 | $124.2M |
| 2022 | $37.0M |
| 2023 | $45.9M |
How accurately did Vericel Corp's revenue projections match actual performance?
Vericel Corp saw the greatest revenue growth in 2015, when revenue increased by 549.73%.
Vericel Corp had the lowest revenue growth in 2022, when revenue changed by -70.17%.
| Year | Vericel Corp growth |
|---|---|
| 2015 | 550%↑ |
| 2016 | 78%↑ |
| 2017 | 6%↑ |
| 2018 | 18%↑ |
| 2019 | 42%↑ |
| 2020 | 30%↑ |
| 2021 | 5%↑ |
| 2022 | -70%↓ |
| 2023 | 24%↑ |
Do you work at Vericel Corp?
Is Vericel Corp transparent about its revenue structure?
| CEO | Dominick C. Colangelo |
| Company Type | Public |
| Employees Number | 216 |
| Date Founded | 1989 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 2 |
| Revenue | $45.9M |
| Net Income | -$5,020,000 |
| Gross Proft | $29.9M (2023) |
| PE Ratio | -149.62 |
| Tax Rate | -0.0% |
| Market Capitalization | $751.1M |
| Total Assets | $310,711,000 |
| Ticker | VCEL |
Vericel Corp received early financing of $40.0M on 2012-03-09.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $40M | 03/2012 |
| Post Ipo Equity | $20M | 12/2016 |
| Post Ipo Equity | $74.8M | 06/2018 |
| Investors | Security type |
|---|---|
| Eastern Capital | Post Ipo Equity |
Vericel Corp's top competitor, Fresenius Kabi, earned an annual revenue of $800.0M.
Vericel Corp's smallest competitor is Lattice Biologics with revenue of $690.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| BioLife Solutions | - | $119.2M | 54 | - |
| Lifecore | - | $150.0M | 255 | - |
| Humacyte | - | $1.6M | 130 | - |
| Goodwin Bio | - | $10.5M | 50 | - |
| SEKISUI Diagnostics | - | $57.0M | 50 | - |
| Fresenius Kabi | - | $800.0M | 72 | - |
| Immucor | - | $380.0M | 1,125 | - |
| RTI Surgical | - | $280.0M | 942 | - |
| HemoSense | - | $4.9M | 50 | - |
| Biomérieux | - | - | 6,828 | - |
Zippia gives an in-depth look into the details of Vericel Corp, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vericel Corp. The employee data is based on information from people who have self-reported their past or current employments at Vericel Corp. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vericel Corp. The data presented on this page does not represent the view of Vericel Corp and its employees or that of Zippia.
Vericel Corp may also be known as or be related to VERICEL CORP, Vericel, Vericel Corp and Vericel Corporation.